| Ms Susan Jill Kupperman, | |
|
411 Chicago Ave, Oak Park, IL 60302-2233 | |
| (708) 524-1050 | |
| Not Available |
| Full Name | Ms Susan Jill Kupperman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 411 Chicago Ave, Oak Park, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124221569 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Susan Jill Kupperman, 1115 N East Ave, Oak Park, IL 60302-1229 Ph: (708) 848-9629 | Ms Susan Jill Kupperman, 411 Chicago Ave, Oak Park, IL 60302-2233 Ph: (708) 524-1050 |
News Archive
An interesting new study describes the activities of a family of viral enzymes called two-histidine-phosphoesterases (2H-PEs), found in coronaviruses (CoVs) and rotaviruses, as well as a mammalian A-kinase anchoring protein enzyme, AKAP7, that shares the same function. Together called 2',5'-PEs, these enzymes all break down 2',5'-oligoadenylate compounds that activate the antiviral enzyme ribonuclease L (RNase L).
Patients with chronic obstructive pulmonary disease and concomitant asthma have significantly more exacerbations and hospitalizations than patients with COPD alone, research shows.
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
MIT researchers have developed a way to make extremely high-resolution images of tissue samples, at a fraction of the cost of other techniques that offer similar resolution.
t first glance, America is making great strides toward a medical and cultural shift in its approach to end-of-life care: More and more providers are recognizing the benefits of hospice, more people are dying at home, and many health care organizations are institutionalizing the discussions between providers and patients that would help patients formalize their wishes for end-of-life care through an advance directive. But pull up the curtain on these statistics, and the drama that unfolds tells a very different story. End-of-life care continues to be characterized by aggressive medical intervention and runaway costs (Adamopoulos, 6/3).
› Verified 2 days ago
Kelly Boris, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 719 N Marion St, Oak Park, IL 60302 Phone: 312-401-0975 | |
Mrs. Anne Elizabeth Ciosek, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 260 Madison St, Oak Park, IL 60302 Phone: 708-524-3110 | |
Madeline S Kubiak, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 429 N Marion St Ste 203, Oak Park, IL 60302 Phone: 312-945-8305 | |
Abbey Blender, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 135 N Harvey Ave, Oak Park, IL 60302 Phone: 917-620-7916 | |
Ms. Julie Cameron, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 411 Chicago Ave, Oak Park, IL 60302 Phone: 708-524-1050 Fax: 708-524-2469 | |
Ics Rehab Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1104 N Taylor Ave, Oak Park, IL 60302 Phone: 708-519-0786 Fax: 708-386-4351 |